Literature DB >> 28120169

Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.

Mahdi Mahmoudi1, Faranak Fallahian2, Soheila Sobhani3, Shima Ghoroghi3, Ahmadreza Jamshidi3, Shiva Poursani3, Masoumeh Dolati2, Zahra Hosseinpour3, Farhad Gharibdoost4.   

Abstract

Genetic factors have a great role in the pathogenesis of autoimmune diseases by cooperating with environmental stimuli. Killer immunoglobulin-like receptors (KIRs) are cell surface proteins on NK cells whose association with major histocompatibility complex-I regulates their killing function. The aim of this study was to provide information on the possible association between KIR and human leukocyte antigen (HLA) genes with systemic sclerosis disease in Iranian population. A total of 279 systemic sclerosis patients and 451 healthy controls were enrolled in this case-control study in order to determine the presence or absence of 19 KIR genes and 6 specific HLA class I ligands. DNA was analyzed by polymerase chain reaction using the specific sequence primer method (PCR-SSP). Among 11 discovered KIR genotypes, 6 genotypes showed a considerable role and 4 genotypes could preclude the risk of systemic sclerosis (SSc) disease. The gene-gene interactions were also analyzed, and significant confounding effects were seen between involved genes in these two combinations: "KIR3DL1; HLA-BW4-Thr80" and "KIR3DL1 -HLA-BW4-A1." None of single KIR genes showed significant effect on the risk of SSc. We conclude that there is an important relationship between KIR genes and their HLA ligands with incidence rate of systemic sclerosis in Iranian population. The powerful role of a number of discovered KIR/HLA compounds such as activating KIR genotype 3 and HLA-BW4-A1 confirmed the provocative hypothesis of the interplay between activating or inhibitory KIR genes with HLA ligands as a critical index of systemic sclerosis predisposition.

Entities:  

Keywords:  KIR; KIR HLA ligand; NK cell; Systemic sclerosis

Mesh:

Substances:

Year:  2017        PMID: 28120169     DOI: 10.1007/s10067-016-3526-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  40 in total

Review 1.  MHC class I molecules and KIRs in human history, health and survival.

Authors:  Peter Parham
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

2.  Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity.

Authors:  Michael J Ombrello; Yohei Kirino; Paul I W de Bakker; Ahmet Gül; Daniel L Kastner; Elaine F Remmers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

3.  Pathogenesis of scleroderma. Current concepts.

Authors:  E B Lee; G J Anhalt; J J Voorhees; L A Diaz
Journal:  Int J Dermatol       Date:  1984-03       Impact factor: 2.736

4.  Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases.

Authors:  I Puxeddu; F Bongiorni; D Chimenti; S Bombardieri; A Moretta; C Bottino; P Migliorini
Journal:  Scand J Rheumatol       Date:  2012-05-28       Impact factor: 3.641

5.  Characteristics of NK cell activity in patients with systemic sclerosis.

Authors:  Patricia Hartstein Salim; Mariana Jobim; Markus Bredemeier; José Artur Bogo Chies; João Carlos Tavares Brenol; Luiz Fernando Jobim; Ricardo Machado Xavier
Journal:  Rev Bras Reumatol       Date:  2013-02

Review 6.  Scleroderma epidemiology.

Authors:  Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

7.  Distribution of KIR genes in the Iranian population.

Authors:  N Tajik; F Shahsavar; T Mousavi; M F Radjabzadeh
Journal:  Tissue Antigens       Date:  2009-04-21

8.  STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.

Authors:  P Dieudé; M Guedj; J Wipff; B Ruiz; E Hachulla; E Diot; B Granel; J Sibilia; K Tiev; L Mouthon; J L Cracowski; P H Carpentier; Z Amoura; I Fajardy; J Avouac; O Meyer; A Kahan; C Boileau; Y Allanore
Journal:  Arthritis Rheum       Date:  2009-08

9.  BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians.

Authors:  B Rueda; P Gourh; J Broen; S K Agarwal; C Simeon; N Ortego-Centeno; M C Vonk; M Coenen; G Riemekasten; N Hunzelmann; R Hesselstrand; F K Tan; J D Reveille; S Assassi; F J Garcia-Hernandez; P Carreira; M Camps; A Fernandez-Nebro; P Garcia de la Peña; T Nearney; D Hilda; M A Gónzalez-Gay; P Airo; L Beretta; R Scorza; T R D J Radstake; M D Mayes; F C Arnett; J Martin
Journal:  Ann Rheum Dis       Date:  2009-10-08       Impact factor: 19.103

Review 10.  Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.

Authors:  Hiroshi Terunuma; Xuewen Deng; Zahidunnabi Dewan; Shigeyoshi Fujimoto; Naoki Yamamoto
Journal:  Int Rev Immunol       Date:  2008       Impact factor: 5.311

View more
  8 in total

1.  Overexpression of apoptosis-related protein, survivin, in fibroblasts from patients with systemic sclerosis.

Authors:  Mohammad Bagher Mahmoudi; Ehsan Farashahi Yazd; Farhad Gharibdoost; Mohammad Hasan Sheikhha; Elham Karimizadeh; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Ir J Med Sci       Date:  2019-02-13       Impact factor: 1.568

2.  Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes.

Authors:  Aimee L Hanson; Joanne Sahhar; Gene-Siew Ngian; Janet Roddy; Jennifer Walker; Wendy Stevens; Mandana Nikpour; Shervin Assassi; Susanna Proudman; Maureen D Mayes; Tony J Kenna; Matthew A Brown
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

Review 3.  The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis.

Authors:  Anwar Fathollahi; Saeed Aslani; Shayan Mostafaei; Nima Rezaei; Mahdi Mahmoudi
Journal:  Inflamm Res       Date:  2018-06-04       Impact factor: 4.575

4.  Association study between KIR polymorphisms and rheumatoid arthritis disease: an updated meta-analysis.

Authors:  Hamideh Aghaei; Shayan Mostafaei; Saeed Aslani; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  BMC Med Genet       Date:  2019-01-29       Impact factor: 2.103

5.  KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico.

Authors:  Andrea Carolina Machado-Sulbaran; María Guadalupe Ramírez-Dueñas; José Eduardo Navarro-Zarza; José Francisco Muñoz-Valle; Francisco Mendoza-Carrera; Christian Johana Baños-Hernández; Isela Parra-Rojas; Margarita Montoya-Buelna; Pedro Ernesto Sánchez-Hernández
Journal:  J Immunol Res       Date:  2019-01-06       Impact factor: 4.818

Review 6.  Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?

Authors:  Elena Gianchecchi; Domenico V Delfino; Alessandra Fierabracci
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

Review 7.  HLA imputation and its application to genetic and molecular fine-mapping of the MHC region in autoimmune diseases.

Authors:  Tatsuhiko Naito; Yukinori Okada
Journal:  Semin Immunopathol       Date:  2021-11-16       Impact factor: 9.623

8.  Integration of Genome-Wide DNA Methylation and Transcription Uncovered Aberrant Methylation-Regulated Genes and Pathways in the Peripheral Blood Mononuclear Cells of Systemic Sclerosis.

Authors:  Honglin Zhu; Chengsong Zhu; Wentao Mi; Tao Chen; Hongjun Zhao; Xiaoxia Zuo; Hui Luo; Quan-Zhen Li
Journal:  Int J Rheumatol       Date:  2018-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.